MAM
CEAT Indian Supercross Racing League partners with Viacom18
Mumbai: CEAT Indian Supercross Racing League co-founder and director Veer Patel said “Our partnership with Viacom18 signifies a major step forward in expanding the reach of Supercross racing in India. Through JioCinema and Sports18, we aim to bring the thrill and excitement of our races to a diverse and enthusiastic audience, elevating the sport to new heights. With Viacom18’s extensive reach and expertise in live sports streaming and broadcasting, we are confident that this partnership will elevate the CEAT ISRL experience for fans across the country.”
Viacom18 spokesperson said, “We are proud to partner with the inaugural season of the CEAT Indian Supercross League. Adding to our unique array of sporting properties, we will deliver fans the best of Indian riders competing against top international talent across digital and TV platforms.”
CEAT ISRL’s partnership with Viacom18 will facilitate streaming of the races on JioCinema, reaching millions, enabling them to catch all the live action on the go, at their convenience, and on devices of their choice. Additionally, the league will also be broadcast live on the Sports18 network, enhancing viewership.
JioCinema has consistently been setting new benchmarks over the past year in live sports streaming. The IPL 2023 final on JioCinema set a new peak concurrency record for the league as 32.1 million viewers hit play.
For more information on the CEAT ISRL Season One Rider Auction and updates on team selections and riders, please visit the official website at
https://indiansupercrossleague.com/
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
